{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T19:47:03Z","timestamp":1769197623629,"version":"3.49.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1053\/j.seminoncol.2022.07.003","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:33:08Z","timestamp":1658363588000},"page":"220-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comorbidity and life expectancy in shared decision making for lung cancer screening"],"prefix":"10.1053","volume":"49","author":[{"given":"Brett","family":"Bade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Gwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Triplette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renda Soylemez","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Crothers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.chest.2018.10.013","article-title":"Shared decision-making and lung cancer screening: let's get the conversation started","volume":"155","author":"Tanner","year":"2019","journal-title":"Chest"},{"issue":"10","key":"10.1053\/j.seminoncol.2022.07.003_bib0002","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0003","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2022.07.003_sbref0004","article-title":"National Center for Health Promotion and Disease Prevention","year":"2021","journal-title":"Screen Lung Cancer"},{"issue":"24","key":"10.1053\/j.seminoncol.2022.07.003_bib0005","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1002\/cncr.29677","article-title":"Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening","volume":"121","author":"Howard","year":"2015","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2022.07.003_sbref0006","article-title":"National Cancer Institute S, Epidemiology, and End Results Program","year":"2021","journal-title":"Cancer Stat Facts"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0007","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.201705-0914OC","article-title":"Assessing the generalizability of the National Lung Screening Trial: comparison of patients with stage 1 disease","volume":"196","author":"Tanner","year":"2017","journal-title":"Am J Resp Crit Care"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.003_bib0008","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1053\/j.seminoncol.2022.07.003_bib0009","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/jnci\/djq434","article-title":"Baseline characteristics of participants in the randomized national lung screening trial","volume":"102","author":"Aberle","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2012.02.021","article-title":"Generalizability of the results of the Dutch-Belgian randomized controlled lung cancer CT screening trial (NELSON): does self-selection play a role?","volume":"77","author":"van der Aalst","year":"2012","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0011","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/JTO.0000000000000488","article-title":"Baseline characteristics and mortality outcomes of control group participants and eligible non-responders in the NELSON lung cancer screening study","volume":"10","author":"Yousaf-Khan","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0012","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamainternmed.2018.6277","article-title":"Complication rates and downstream medical costs associated with invasive diagnostic procedures for lung abnormalities in the community setting","volume":"179","author":"Huo","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0013","doi-asserted-by":"crossref","first-page":"pkaa053","DOI":"10.1093\/jncics\/pkaa053","article-title":"national lung cancer screening utilization trends in the veterans\u2019 health administration","volume":"4","author":"Lewis","year":"2020","journal-title":"JNCI Cancer Spectr"},{"issue":"11","key":"10.1053\/j.seminoncol.2022.07.003_bib0014","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1513\/AnnalsATS.202010-1276OC","article-title":"Comorbidity profiles and lung cancer screening among older adults: US behavioral risk factor surveillance system 2017 to 2019","volume":"18","author":"Advani","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"10.1053\/j.seminoncol.2022.07.003_bib0015","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1164\/rccm.201505-0894OC","article-title":"Airflow limitation and histology shift in the National Lung Screening Trial. The NLST-ACRIN cohort substudy","volume":"192","author":"Young","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0016","doi-asserted-by":"crossref","first-page":"1601721","DOI":"10.1183\/13993003.01721-2016","article-title":"Comorbidities in the management of patients with lung cancer","volume":"49","author":"Leduc","year":"2017","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1053\/j.seminoncol.2022.07.003_bib0017","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for lung cancer: US preventive services task force recommendation statement","volume":"325","author":"Force","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0018","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJMoa1211776","article-title":"Selection criteria for lung-cancer screening","volume":"368","author":"Tammemagi","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.seminoncol.2022.07.003_bib0019","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jamaoncol.2019.1402","article-title":"Evaluation of USPSTF lung cancer screening guidelines among African American adult smokers","volume":"5","author":"Aldrich","year":"2019","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1053\/j.seminoncol.2022.07.003_bib0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/M19-1263","article-title":"Life-gained-based versus risk-based selection of smokers for lung cancer screening","volume":"171","author":"Cheung","year":"2019","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0021","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1016\/j.chest.2021.06.063","article-title":"Screening for lung cancer: CHEST guideline and expert panel report","volume":"160","author":"Mazzone","year":"2021","journal-title":"Chest"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0022","doi-asserted-by":"crossref","first-page":"243","DOI":"10.21037\/tlcr.2018.06.03","article-title":"Selecting lung cancer screenees using risk prediction models-where do we go from here","volume":"7","author":"Tammemagi","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1053\/j.seminoncol.2022.07.003_sbref0023","article-title":"United States Preventive Services Task Force","year":"2014","journal-title":"Final Recomm Statement Lung Cancer"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0024","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamainternmed.2016.9022","article-title":"Implementation of lung cancer screening in the veterans health administration","volume":"177","author":"Kinsinger","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.003_bib0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/COC.0b013e3181fe445b","article-title":"Predictive ability of Charlson comorbidity index on outcomes from lung cancer","volume":"34","author":"Ganti","year":"2011","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0026","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/0284186X.2020.1764096","article-title":"Comorbidity and early death in Danish stage I lung cancer patients - an individualized approach","volume":"59","author":"Christensen","year":"2020","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0027","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1186\/s12885-018-5000-7","article-title":"Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries","volume":"18","author":"Seigneurin","year":"2018","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0028","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2188\/jea.JE20170241","article-title":"Impact of comorbidities on survival in gastric, colorectal, and lung cancer patients","volume":"29","author":"Morishima","year":"2019","journal-title":"J Epidemiol"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.003_bib0029","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/1055-9965.EPI-15-0036","article-title":"Comorbidity and survival in lung cancer patients","volume":"24","author":"Islam","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1053\/j.seminoncol.2022.07.003_bib0030","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1513\/AnnalsATS.201701-030OC","article-title":"Comorbidity profiles and their effect on treatment selection and survival among patients with lung cancer","volume":"14","author":"Gould","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"5 Suppl","key":"10.1053\/j.seminoncol.2022.07.003_bib0031","article-title":"Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Howington","year":"2013","journal-title":"Chest."},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.003_bib0032","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccm.2011.09.001","article-title":"Lung cancer: epidemiology, etiology, and prevention","volume":"32","author":"Dela Cruz","year":"2011","journal-title":"Clin Chest Med"},{"issue":"9","key":"10.1053\/j.seminoncol.2022.07.003_bib0033","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/thoraxjnl-2012-203123","article-title":"Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit","volume":"68","author":"Powell","year":"2013","journal-title":"Thorax"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0034","first-page":"2903","article-title":"Preoperative Pulmonary Function Tests (PFTs) and outcomes from resected early stage Non-small Cell Lung Cancer (NSCLC)","volume":"38","author":"Almquist","year":"2018","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0022-5223(19)33821-8","article-title":"Physiologic evaluation of pulmonary function in the candidate for lung resection","volume":"105","author":"Miller","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.003_bib0036","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0003-4975(96)00476-6","article-title":"Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity","volume":"62","author":"Bousamra","year":"1996","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.003_bib0037","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/09031936.98.12061429","article-title":"Invasive exercise testing in the evaluation of patients at high-risk for lung resection","volume":"12","author":"Ribas","year":"1998","journal-title":"Eur Respir J"},{"issue":"5 Suppl","key":"10.1053\/j.seminoncol.2022.07.003_bib0038","doi-asserted-by":"crossref","first-page":"e166S","DOI":"10.1378\/chest.12-2395","article-title":"Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Brunelli","year":"2013","journal-title":"Chest."},{"issue":"21","key":"10.1053\/j.seminoncol.2022.07.003_bib0039","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1001\/archinte.167.21.2361","article-title":"A framework for tailoring clinical guidelines to comorbidity at the point of care","volume":"167","author":"Braithwaite","year":"2007","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.003_bib0040","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/MLR.0b013e31819748d5","article-title":"The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines","volume":"47","author":"Braithwaite","year":"2009","journal-title":"Med Care"},{"issue":"12","key":"10.1053\/j.seminoncol.2022.07.003_bib0041","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s11606-011-1816-4","article-title":"Assessing the impact of screening colonoscopy on mortality in the medicare population","volume":"26","author":"Gross","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.003_bib0042","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0043","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201805-0986ST","article-title":"Incorporating coexisting chronic illness into decisions about patient selection for lung cancer screening. An official American Thoracic Society Research Statement","volume":"198","author":"Rivera","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M17-2561","article-title":"Identifying patients for whom lung cancer screening is preference-sensitive: a microsimulation study","volume":"169","author":"Caverly","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5489\/cuaj.11161","article-title":"Challenging the 10-year rule: the accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management","volume":"6","author":"Leung","year":"2012","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0046","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0272989X07311756","article-title":"Resident physicians' life expectancy estimates and colon cancer screening recommendations in elderly patients","volume":"28","author":"Lewis","year":"2008","journal-title":"Med Decis Making"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.003_bib0047","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.chest.2018.01.016","article-title":"Screening for lung cancer: CHEST guideline and expert panel report","volume":"153","author":"Mazzone","year":"2018","journal-title":"Chest"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0048","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.chest.2020.12.004","article-title":"Quantitative emphysema on low-dose CT imaging of the chest and risk of lung cancer and airflow obstruction: an analysis of the National Lung Screening Trial","volume":"159","author":"Labaki","year":"2021","journal-title":"Chest."},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0049","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12890-020-01344-y","article-title":"Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population","volume":"20","author":"Goffin","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.003_bib0050","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1513\/AnnalsATS.201911-857OC","article-title":"Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in a lung cancer screening cohort","volume":"17","author":"Ruparel","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1053\/j.seminoncol.2022.07.003_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106245","article-title":"Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study","volume":"176","author":"Gazourian","year":"2021","journal-title":"Respir Med"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0052","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mayocpiqo.2018.12.003","article-title":"Use of lung cancer screening with low-dose computed tomography in the medicare population","volume":"3","author":"Nishi","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"12","key":"10.1053\/j.seminoncol.2022.07.003_bib0053","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/carcin\/bgab082","article-title":"Association between previous lung diseases and lung cancer risk: a systematic review and meta-analysis","volume":"42","author":"Ang","year":"2021","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0054","doi-asserted-by":"crossref","first-page":"160","DOI":"10.21037\/atm.2016.03.57","article-title":"Lung cancer screening in patients with chronic obstructive pulmonary disease","volume":"4","author":"Gonzalez","year":"2016","journal-title":"Ann Transl Med"},{"issue":"9","key":"10.1053\/j.seminoncol.2022.07.003_bib0055","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1513\/AnnalsATS.201602-091OC","article-title":"Factors associated with a positive baseline screening exam result in the National Lung Screening Trial","volume":"13","author":"Balekian","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"Suppl 2","key":"10.1053\/j.seminoncol.2022.07.003_bib0056","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.acra.2020.07.040","article-title":"Factors influencing the false positive rate in CT lung cancer screening","volume":"Suppl 2","author":"Hammer","year":"2022","journal-title":"Acad Radiol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0057","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1513\/AnnalsATS.202011-1413OC","article-title":"Community-based lung cancer screening results in relation to patient and radiologist characteristics: the PROSPR consortium","volume":"19","author":"Burnett-Hartman","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0058","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-155-3-201108020-00003","article-title":"Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records","volume":"155","author":"Wiener","year":"2011","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0059","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.chest.2019.06.016","article-title":"Patient-level trajectories and outcomes after low-dose CT screening in the National Lung Screening Trial","volume":"156","author":"Iaccarino","year":"2019","journal-title":"Chest"},{"key":"10.1053\/j.seminoncol.2022.07.003_bib0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.lungcan.2019.07.015","article-title":"Airflow limitation and survival after surgery for non-small cell lung cancer: results from a systematic review and lung cancer screening trial (NLST-ACRIN sub-study)","volume":"135","author":"Hopkins","year":"2019","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0061","doi-asserted-by":"crossref","first-page":"347","DOI":"10.21037\/tlcr.2018.05.04","article-title":"Chronic obstructive pulmonary disease (COPD) and lung cancer screening","volume":"7","author":"Young","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1053\/j.seminoncol.2022.07.003_bib0062","article-title":"Self-reported exercise capacity among current smokers eligible for lung cancer screening: distribution and association with key comorbidities","volume":"28","author":"Melzer","year":"2021","journal-title":"Cancer Treat Res Commun"},{"issue":"19","key":"10.1053\/j.seminoncol.2022.07.003_bib0063","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0064","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1513\/AnnalsATS.201807-481OC","article-title":"Idiopathic pulmonary fibrosis and lung cancer: a systematic review and meta-analysis","volume":"16","author":"Whittaker Brown","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202360","article-title":"Lung cancer in idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"13","author":"JafariNezhad","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.003_bib0066","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.chest.2019.06.041","article-title":"Interstitial lung abnormalities and lung cancer risk in the National Lung Screening Trial","volume":"156","author":"Whittaker Brown","year":"2019","journal-title":"Chest"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0067","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4143\/crt.2017.119","article-title":"Interstitial lung disease and lung cancer development: a 5-Year Nationwide Population-Based Study","volume":"50","author":"Choi","year":"2018","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0068","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12931-018-0899-4","article-title":"Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data","volume":"19","author":"Yoon","year":"2018","journal-title":"Respir Res"},{"key":"10.1053\/j.seminoncol.2022.07.003_bib0069","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40248-018-0150-7","article-title":"Prevalence, risk factors, and impact of lung cancer on outcomes of idiopathic pulmonary fibrosis: a study from the Middle East","volume":"13","author":"Mohamed","year":"2018","journal-title":"Multidiscip Respir Med"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1378\/chest.14-0359","article-title":"The impact of lung cancer on survival of idiopathic pulmonary fibrosis","volume":"147","author":"Tomassetti","year":"2015","journal-title":"Chest"},{"issue":"10","key":"10.1053\/j.seminoncol.2022.07.003_bib0071","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.rmed.2014.07.020","article-title":"Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival","volume":"108","author":"Lee","year":"2014","journal-title":"Respir Med"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0072","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00432-016-2199-z","article-title":"Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival","volume":"142","author":"Kanaji","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0073","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3892\/mco.2016.954","article-title":"Clinical features and outcomes of patients with lung cancer as well as combined pulmonary fibrosis and emphysema","volume":"5","author":"Otsuka","year":"2016","journal-title":"Mol Clin Oncol"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0074","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1513\/AnnalsATS.201808-510OC","article-title":"Outcomes of older patients with pulmonary fibrosis and non-small cell lung cancer","volume":"16","author":"Whittaker Brown","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.lungcan.2013.11.016","article-title":"Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: a systematic review and meta-analysis of clinical trials","volume":"83","author":"Shi","year":"2014","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0076","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ccm.2016.12.012","article-title":"Pulmonary toxicities from checkpoint immunotherapy for malignancy","volume":"38","author":"Possick","year":"2017","journal-title":"Clin Chest Med"},{"key":"10.1053\/j.seminoncol.2022.07.003_bib0077","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.lungcan.2018.10.001","article-title":"Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: a retrospective analysis","volume":"125","author":"Yamaguchi","year":"2018","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0078","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jtcvs.2013.09.050","article-title":"Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer","volume":"147","author":"Sato","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0079","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jtcvs.2014.08.086","article-title":"Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases","volume":"149","author":"Sato","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13014-019-1221-4","article-title":"Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy","volume":"14","author":"Kim","year":"2019","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.003_bib0081","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/cid\/cix392","article-title":"Cancer-attributable mortality among people with treated human immunodeficiency virus infection in North America","volume":"65","author":"Engels","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1053\/j.seminoncol.2022.07.003_bib0082","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/M17-2499","article-title":"Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030","volume":"168","author":"Shiels","year":"2018","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1053\/j.seminoncol.2022.07.003_bib0083","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1093\/cid\/ciaa1016","article-title":"Deaths attributable to cancer in the US human immunodeficiency virus population during 2001-2015","volume":"72","author":"Horner","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0084","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/518606","article-title":"HIV infection is associated with an increased risk for lung cancer, independent of smoking","volume":"45","author":"Kirk","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.003_bib0085","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju503","article-title":"Excess cancers among HIV-infected people in the United States","volume":"107","author":"Robbins","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.003_bib0086","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","article-title":"Cumulative incidence of cancer among persons with HIV in North America: a cohort study","volume":"163","author":"Silverberg","year":"2015","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.003_bib0087","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/0003-4819-153-7-201010050-00008","article-title":"Age at cancer diagnosis among persons with AIDS in the United States","volume":"153","author":"Shiels","year":"2010","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0088","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0089","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/QAD.0b013e328352d1ad","article-title":"HIV as an independent risk factor for incident lung cancer","volume":"26","author":"Sigel","year":"2012","journal-title":"AIDS"},{"issue":"12","key":"10.1053\/j.seminoncol.2022.07.003_bib0090","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/cir207","article-title":"Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy","volume":"52","author":"Kesselring","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1053\/j.seminoncol.2022.07.003_bib0091","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","article-title":"Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study","volume":"10","author":"Guiguet","year":"2009","journal-title":"Lancet Oncol"},{"issue":"9581","key":"10.1053\/j.seminoncol.2022.07.003_bib0092","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0093","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/S2352-3018(16)30215-6","article-title":"Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study","volume":"4","author":"Sigel","year":"2017","journal-title":"Lancet HIV"},{"issue":"9","key":"10.1053\/j.seminoncol.2022.07.003_bib0094","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/QAD.0b013e32835f6b0c","article-title":"Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers","volume":"27","author":"Borges","year":"2013","journal-title":"AIDS"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.003_bib0095","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/QAD.0000000000001434","article-title":"Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals","volume":"31","author":"Marcus","year":"2017","journal-title":"AIDS"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0096","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QAI.0b013e3181eef4f7","article-title":"Pulmonary infections and risk of lung cancer among persons with AIDS","volume":"55","author":"Shebl","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0097","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"National Lung Screening Trial Research","year":"2011","journal-title":"New Engl J Med"},{"issue":"10","key":"10.1053\/j.seminoncol.2022.07.003_bib0098","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0000000000001818","article-title":"Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells\/mul","volume":"32","author":"Kong","year":"2018","journal-title":"AIDS"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0099","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/hiv.12811","article-title":"Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohort","volume":"21","author":"Makinson","year":"2020","journal-title":"HIV Med"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.003_bib0100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/JTO.0000000000000161","article-title":"Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers","volume":"9","author":"Hulbert","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.003_bib0101","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/QAD.0000000000000943","article-title":"Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers","volume":"30","author":"Makinson","year":"2016","journal-title":"AIDS (London, England)"},{"key":"10.1053\/j.seminoncol.2022.07.003_bib0102","article-title":"Frequency of complications after lung biopsy in HIV-infected compared to HIV-uninfected patients: implications for lung cancer screening","author":"Sigel","year":"2015","journal-title":"Am Thorac Soc Int Conf"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.003_bib0103","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/QAD.0000000000000189","article-title":"Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening","volume":"28","author":"Sigel","year":"2014","journal-title":"AIDS"},{"issue":"12","key":"10.1053\/j.seminoncol.2022.07.003_bib0104","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/QAD.0000000000001529","article-title":"Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: implications for lung cancer screening","volume":"31","author":"Triplette","year":"2017","journal-title":"AIDS"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/apc.2018.0190","article-title":"Non-HIV comorbid conditions and polypharmacy among people living with HIV Age 65 or older compared with HIV-negative individuals age 65 or older in the United States: a retrospective claims-based analysis","volume":"33","author":"Kong","year":"2019","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0106","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/hiv.12683","article-title":"Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) foundation study cohort in the period 2004-2014","volume":"20","author":"d'Arminio Monforte","year":"2019","journal-title":"HIV Med"},{"issue":"16","key":"10.1053\/j.seminoncol.2022.07.003_bib0107","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/QAD.0000000000001967","article-title":"Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort","volume":"32","author":"Pelchen-Matthews","year":"2018","journal-title":"AIDS"},{"issue":"9","key":"10.1053\/j.seminoncol.2022.07.003_bib0108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184583","article-title":"Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES)","volume":"12","author":"Petoumenos","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0109","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/cix998","article-title":"Multimorbidity among persons living with human immunodeficiency virus in the United States","volume":"66","author":"Wong","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0110","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12879-019-4184-z","article-title":"Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study","volume":"19","author":"Maggi","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.003_bib0111","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","article-title":"Future challenges for clinical care of an ageing population infected with HIV: a modelling study","volume":"15","author":"Smit","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1053\/j.seminoncol.2022.07.003_bib0112","doi-asserted-by":"crossref","unstructured":"Crothers K, Sigel K, Braithwaite R, et al. Tailoring lung cancer screening in the context of HIV and comorbidity: a simulation study. American Thoracic Society International Conference May 22; Dallas 202, TX. 2019.","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A5892"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0113","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/QAI.0b013e31827df36c","article-title":"Predictive accuracy of the veterans aging cohort study index for mortality with HIV infection: a North American cross cohort analysis","volume":"62","author":"Justice","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.003_bib0114","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/QAD.0b013e32835b8c7f","article-title":"An internationally generalizable risk index for mortality after one year of antiretroviral therapy","volume":"27","author":"Tate","year":"2013","journal-title":"AIDS"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0115","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/QAD.0000000000002140","article-title":"Veterans aging cohort S, the antiretroviral therapy cohort C. albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals","volume":"33","author":"Tate","year":"2019","journal-title":"AIDS"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.003_bib0116","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.16233","article-title":"Adherence to follow-up testing recommendations in US veterans screened for lung cancer, 2015-2019","volume":"4","author":"Nunez","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.003_bib0117","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s11606-014-3163-8","article-title":"Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration","volume":"30","author":"Powell","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1053\/j.seminoncol.2022.07.003_bib0118","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1001\/jamainternmed.2014.3895","article-title":"Cancer screening rates in individuals with different life expectancies","volume":"174","author":"Royce","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.003_bib0119","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/0272989X15572828","article-title":"Relationship between physicians' uncertainty about clinical assessments and patient-centered recommendations for colorectal cancer screening in the elderly","volume":"35","author":"Dalton","year":"2015","journal-title":"Med Decis Making"},{"issue":"11","key":"10.1053\/j.seminoncol.2022.07.003_bib0120","first-page":"1667","article-title":"A national survey of pulmonologists' views on low-dose computed tomography screening for lung cancer","volume":"12","author":"Iaccarino","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.003_bib0121","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s11606-018-4350-9","article-title":"Patient and clinician perspectives on shared decision-making in early adopting lung cancer screening programs: a qualitative study","volume":"33","author":"Wiener","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0122","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11606-019-05516-3","article-title":"What exactly is shared decision-making? A qualitative study of shared decision-making in lung cancer screening","volume":"35","author":"Melzer","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.07.003_bib0123","first-page":"546","article-title":"Primary care physician perceptions of shared decision making in lung cancer screening","volume":"35","author":"Abubaker-Sharif","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0124","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jamainternmed.2016.0670","article-title":"Primary care practitioners' views on incorporating long-term prognosis in the care of older adults","volume":"176","author":"Schoenborn","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0125","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamainternmed.2017.1778","article-title":"Older adults' views and communication preferences about cancer screening cessation","volume":"177","author":"Schoenborn","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.07.003_bib0126","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1370\/afm.2309","article-title":"Older adults' preferences for discussing long-term life expectancy: results from a national survey","volume":"16","author":"Schoenborn","year":"2018","journal-title":"Ann Fam Med"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.07.003_bib0127","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamainternmed.2013.2903","article-title":"Older adults and forgoing cancer screening: \"I think it would be strange\"","volume":"173","author":"Torke","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.003_bib0128","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.2196\/medinform.6405","article-title":"Computerized decision aids for shared decision making in serious illness: systematic review","volume":"5","author":"Staszewska","year":"2017","journal-title":"JMIR Med Inform"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.07.003_bib0129","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11606-015-3249-y","article-title":"Reducing PSA-based prostate cancer screening in men aged 75 years and older with the use of highly specific computerized clinical decision support","volume":"30","author":"Shelton","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.07.003_bib0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamainternmed.2015.7339","article-title":"A comparative effectiveness trial of alternate formats for presenting benefits and harms information for low-value screening services: a randomized clinical trial","volume":"176","author":"Sheridan","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1053\/j.seminoncol.2022.07.003_bib0131","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1513\/AnnalsATS.201604-289OC","article-title":"Patients' attitudes regarding lung cancer screening and decision aids. A survey and focus group study","volume":"13","author":"Crothers","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.07.003_bib0132","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.07.003_bib0133","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MLR.0b013e31827da95a","article-title":"Predicting risk of hospitalization or death among patients receiving primary care in the veterans\u2019 health administration","volume":"51","author":"Wang","year":"2013","journal-title":"Med Care"},{"issue":"11","key":"10.1053\/j.seminoncol.2022.07.003_bib0134","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/jnci\/djaa211","article-title":"Using prediction models to reduce persistent racial and ethnic disparities in the draft 2020 USPSTF lung cancer screening guidelines","volume":"113","author":"Landy","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.07.003_bib0135","doi-asserted-by":"crossref","first-page":"ooab041","DOI":"10.1093\/jamiaopen\/ooab041","article-title":"Establishing a multidisciplinary initiative for interoperable electronic health record innovations at an academic medical center","volume":"4","author":"Kawamoto","year":"2021","journal-title":"JAMIA Open"},{"issue":"203","key":"10.1053\/j.seminoncol.2022.07.003_bib0136","first-page":"1","article-title":"Enabling health care decision making through clinical decision support and knowledge management","author":"Lobach","year":"2012","journal-title":"Evid Rep Technol Assess (Full Rep)"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775422000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775422000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:58:56Z","timestamp":1758805136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775422000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":136,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0093775422000574"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2022.07.003","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidity and life expectancy in shared decision making for lung cancer screening","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2022.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}